Upregulation of toll-like receptor 2 by TL1A stimulation in synovial fibroblasts

Chi Ying Wu, Yu Ping Chung, Chian Her Lee, Guo Shu Huang, Herng Sheng Lee

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: TNF-like molecule 1A (TL1A) is a ligand of the tumor necrosis factor (TNF) superfamily that mediates apoptosis and inflammation via its effective receptor DR3 and the activation of NF-κB. Toll-like receptors (TLRs) are receptors that recognize microbes and activate the immune response. Endogenous ligands such as interleukin 1β (IL-1β) and fibronectin fragments also trigger the TLR2-mediated immune response. Recently, the DR3 receptor was found in the synovia of patients with rheumatoid arthritis and osteoarthritis. In this study, we examined the influence of TL1A on the expression of TLRs 1-5 in synovial fibroblasts. Methods: Synovial fibroblasts were isolated from rat knee joints and treated with TL1A for 0, 6, 12, or 24 h. Changes in TLR 1-5 expression were determined by RT-PCR. The expression of TLR2 protein was detected by immunocytochemistry and western blotting. Results: The expression of the Tlr2 was significantly upregulated by TL1A in the first six hours of stimulation. TLR2 protein was also upregulated. The expression of Tlr1 and Tlr3-5 was not significantly affected by TL1A. Conclusions: We have demonstrated for the first time that TLR2 expression is upregulated by TL1A in synovial fibroblasts. DR3 expression in rheumatoid arthritis and osteoarthritis and our findings suggest that TL1A plays a role in the process of articular inflammation and somehow influences the expression of TLR2.

Original languageEnglish
Pages (from-to)27-33
Number of pages7
JournalJournal of Medical Sciences (Taiwan)
Volume28
Issue number1
Publication statusPublished - Feb 2008
Externally publishedYes

Fingerprint

Toll-Like Receptor 2
Receptors, Tumor Necrosis Factor, Member 25
Toll-Like Receptor 5
Toll-Like Receptor 1
Up-Regulation
Fibroblasts
Osteoarthritis
Rheumatoid Arthritis
Tumor Necrosis Factors
Inflammation
Toll-Like Receptors
Synovial Fluid
Knee Joint
Interleukin-1
Fibronectins
Proteins
Tumor Necrosis Factor-alpha
Joints
Western Blotting
Immunohistochemistry

Keywords

  • Synovium
  • TNF-like molecule 1A
  • Toll-like receptor

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Upregulation of toll-like receptor 2 by TL1A stimulation in synovial fibroblasts. / Wu, Chi Ying; Chung, Yu Ping; Lee, Chian Her; Huang, Guo Shu; Lee, Herng Sheng.

In: Journal of Medical Sciences (Taiwan), Vol. 28, No. 1, 02.2008, p. 27-33.

Research output: Contribution to journalArticle

Wu, Chi Ying ; Chung, Yu Ping ; Lee, Chian Her ; Huang, Guo Shu ; Lee, Herng Sheng. / Upregulation of toll-like receptor 2 by TL1A stimulation in synovial fibroblasts. In: Journal of Medical Sciences (Taiwan). 2008 ; Vol. 28, No. 1. pp. 27-33.
@article{79c3579eb05845e4b0a4fa330e59842d,
title = "Upregulation of toll-like receptor 2 by TL1A stimulation in synovial fibroblasts",
abstract = "Background: TNF-like molecule 1A (TL1A) is a ligand of the tumor necrosis factor (TNF) superfamily that mediates apoptosis and inflammation via its effective receptor DR3 and the activation of NF-κB. Toll-like receptors (TLRs) are receptors that recognize microbes and activate the immune response. Endogenous ligands such as interleukin 1β (IL-1β) and fibronectin fragments also trigger the TLR2-mediated immune response. Recently, the DR3 receptor was found in the synovia of patients with rheumatoid arthritis and osteoarthritis. In this study, we examined the influence of TL1A on the expression of TLRs 1-5 in synovial fibroblasts. Methods: Synovial fibroblasts were isolated from rat knee joints and treated with TL1A for 0, 6, 12, or 24 h. Changes in TLR 1-5 expression were determined by RT-PCR. The expression of TLR2 protein was detected by immunocytochemistry and western blotting. Results: The expression of the Tlr2 was significantly upregulated by TL1A in the first six hours of stimulation. TLR2 protein was also upregulated. The expression of Tlr1 and Tlr3-5 was not significantly affected by TL1A. Conclusions: We have demonstrated for the first time that TLR2 expression is upregulated by TL1A in synovial fibroblasts. DR3 expression in rheumatoid arthritis and osteoarthritis and our findings suggest that TL1A plays a role in the process of articular inflammation and somehow influences the expression of TLR2.",
keywords = "Synovium, TNF-like molecule 1A, Toll-like receptor",
author = "Wu, {Chi Ying} and Chung, {Yu Ping} and Lee, {Chian Her} and Huang, {Guo Shu} and Lee, {Herng Sheng}",
year = "2008",
month = "2",
language = "English",
volume = "28",
pages = "27--33",
journal = "Journal of Medical Sciences",
issn = "1011-4564",
publisher = "國防醫學院",
number = "1",

}

TY - JOUR

T1 - Upregulation of toll-like receptor 2 by TL1A stimulation in synovial fibroblasts

AU - Wu, Chi Ying

AU - Chung, Yu Ping

AU - Lee, Chian Her

AU - Huang, Guo Shu

AU - Lee, Herng Sheng

PY - 2008/2

Y1 - 2008/2

N2 - Background: TNF-like molecule 1A (TL1A) is a ligand of the tumor necrosis factor (TNF) superfamily that mediates apoptosis and inflammation via its effective receptor DR3 and the activation of NF-κB. Toll-like receptors (TLRs) are receptors that recognize microbes and activate the immune response. Endogenous ligands such as interleukin 1β (IL-1β) and fibronectin fragments also trigger the TLR2-mediated immune response. Recently, the DR3 receptor was found in the synovia of patients with rheumatoid arthritis and osteoarthritis. In this study, we examined the influence of TL1A on the expression of TLRs 1-5 in synovial fibroblasts. Methods: Synovial fibroblasts were isolated from rat knee joints and treated with TL1A for 0, 6, 12, or 24 h. Changes in TLR 1-5 expression were determined by RT-PCR. The expression of TLR2 protein was detected by immunocytochemistry and western blotting. Results: The expression of the Tlr2 was significantly upregulated by TL1A in the first six hours of stimulation. TLR2 protein was also upregulated. The expression of Tlr1 and Tlr3-5 was not significantly affected by TL1A. Conclusions: We have demonstrated for the first time that TLR2 expression is upregulated by TL1A in synovial fibroblasts. DR3 expression in rheumatoid arthritis and osteoarthritis and our findings suggest that TL1A plays a role in the process of articular inflammation and somehow influences the expression of TLR2.

AB - Background: TNF-like molecule 1A (TL1A) is a ligand of the tumor necrosis factor (TNF) superfamily that mediates apoptosis and inflammation via its effective receptor DR3 and the activation of NF-κB. Toll-like receptors (TLRs) are receptors that recognize microbes and activate the immune response. Endogenous ligands such as interleukin 1β (IL-1β) and fibronectin fragments also trigger the TLR2-mediated immune response. Recently, the DR3 receptor was found in the synovia of patients with rheumatoid arthritis and osteoarthritis. In this study, we examined the influence of TL1A on the expression of TLRs 1-5 in synovial fibroblasts. Methods: Synovial fibroblasts were isolated from rat knee joints and treated with TL1A for 0, 6, 12, or 24 h. Changes in TLR 1-5 expression were determined by RT-PCR. The expression of TLR2 protein was detected by immunocytochemistry and western blotting. Results: The expression of the Tlr2 was significantly upregulated by TL1A in the first six hours of stimulation. TLR2 protein was also upregulated. The expression of Tlr1 and Tlr3-5 was not significantly affected by TL1A. Conclusions: We have demonstrated for the first time that TLR2 expression is upregulated by TL1A in synovial fibroblasts. DR3 expression in rheumatoid arthritis and osteoarthritis and our findings suggest that TL1A plays a role in the process of articular inflammation and somehow influences the expression of TLR2.

KW - Synovium

KW - TNF-like molecule 1A

KW - Toll-like receptor

UR - http://www.scopus.com/inward/record.url?scp=41149115547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41149115547&partnerID=8YFLogxK

M3 - Article

VL - 28

SP - 27

EP - 33

JO - Journal of Medical Sciences

JF - Journal of Medical Sciences

SN - 1011-4564

IS - 1

ER -